ALPINE, UT, Aug. 29 /PRNewswire-FirstCall/ - American Biotech Labs,
developer of a new class of products based on the company's patented
nano-catalytic SilverSol Technology(TM), today announced that a preliminary
study of the effect of the company's ASAP 10 treatment on HIV-positive
individuals has been published in the first issue of the Journal of the
Science of Healing Outcomes (JSHO; www.thejsho.com/pdf/Effect.pdf). JSHO is
a scholarly health journal that publishes compelling new medical research
data and reports.
The study was conducted over four months with seven HIV-positive
patients, each of whom was administered 15 ml of ABL ASAP 10 ppm (parts per
million) four times daily. As a result of the ABL treatment, "Clinically,
(the patients) were 100 percent fit and were feeling much better after the
treatment period," said Dr. B.M. Hegde, world-renowned cardiologist and
editor of JSHO.
During the course of the therapy, the patients experienced an average
body weight gain of eight kilograms (17.6 pounds) and an average
T-lymphocyte count increase of 180 per micro-liter (39.52 percent).
One of the study's most significant findings, said Hegde, was the
effect of ABL ASAP on HIV, the AIDS-causing virus. "Our recent laboratory
work of the effect of nano silver in vitro on the... virus did show that
the nanosilver particles could bind to (HIV) and could potentially block
the viral entry into cells, eventually destroying the virus."
Hegde added, "Now that we have the laboratory results of the drug's
efficacy and safety, we are planning a large scale controlled study of the
application to HIV positive individuals in the near future."
About American Biotech Labs
American Biotech Labs (ABL; www.AmericanBiotechLabs.com), founded in
1998, utilizes patented processes and SilverSol Technology(TM) to create
singularly powerful and effective nano-catalytic silver products. In
extensive testing performed by a variety of respected laboratories and
researchers, ABL's silver hydrosol has consistently demonstrated the
ability, without any known toxic side effects, to destroy a wide range of
bacteria, viruses, yeast, and molds. ABL products have been approved by the
U.S. EPA as a disinfectant for dental water lines, and as a surface
disinfectant for bacteria, yeast and mold in hospital, residential,
commercial and industrial settings. The company's products are sold
worldwide at health food stores and by medical professionals under the
Silver Biotics(R) and ASAP Solution(R) brands and through a variety of
SOURCE Clifton Mining Company